Medical device manufacturers could soon be looking at additional expenses following proposed changes to the Physician Payment Sunshine Act. The changes were proposed by the Centers for Medicare & Medicaid Services (CMS) and are designed to correct certain unintended consequences of the current text and make policy consistent with that of the drug and biologics industries. The most notable change for devicemakers, said law firm King and Spalding, would be reporting the names of all products associated with a particular payment. Companies would be forced to make "significant and expensive upgrades" to their data systems to accommodate the new policies. The changes are slated to take effect Jan. 1, 2015, and would impact data collection for 2014. Story